UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 71

Sortiert nach

Intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinomas: predictors and impact on subsequent oncological outcomes from a national multicenter study

World journal of urology, 2013-02, Vol.31 (1), p.61-68

2013

Link zum Volltext

Verfügbarkeit prüfen

Influence of previous or synchronous bladder cancer on oncologic outcomes after radical nephroureterectomy for upper urinary tract urothelial carcinoma

Urologic oncology, 2014, Vol.32 (1), p.23.e1-23.e8

2014

Link zum Volltext

Verfügbarkeit prüfen

The percentage of prostate‐specific antigen (PSA) isoform [–2]proPSA and the Prostate Health Index improve the diagnostic accuracy for clinically relevant prostate cancer at initial and repeat biopsy compared with total PSA and percentage free PSA in men aged ≤65 years

BJU international, 2016-01, Vol.117 (1), p.72-79

2016

Link zum Volltext

Verfügbarkeit prüfen

Congenital Pelvic Arteriovenous Malformation in Male Patients: A Rare Cause of Urological Symptoms and Role of Embolization

European urology, 2002-10, Vol.42 (4), p.407-412

2002

Link zum Volltext

Verfügbarkeit prüfen

Cancer du testicule

Houlgatte, Alain

1, 2005

Link zum Volltext

Verfügbarkeit prüfen

Cancer du testicule

Houlgatte, Alain

1. Aufl., 2005

Link zum Volltext

Verfügbarkeit prüfen

2133 [-2]PROPSA AND PROSTATE HEALTH INDEX (PHI) IMPROVE DETECTION OF PROSTATE CANCER AT INITIAL AND REPEATED BIOPSIES IN YOUNG MEN (<60 YEAR OLD) PREFERENTIALLY DETECTING CLINICALLY SIGNIFICANT CANCER

The Journal of urology, 2013-04, Vol.189 (4), p.e873-e874

2013

Link zum Volltext

Verfügbarkeit prüfen

Simulation Training in Endo-urology: a New Opportunity for Training in Senegal

Current bladder dysfunction reports, 2020-12, Vol.15 (4), p.366-370

2020

Link zum Volltext

Verfügbarkeit prüfen

The percentage of prostate‐specific antigen ( PSA ) isoform [–2]pro PSA and the Prostate Health Index improve the diagnostic accuracy for clinically relevant prostate cancer at initial and repeat biopsy compared with total PSA and percentage free PSA in men aged ≤65 years

BJU international, 2016-01, Vol.117 (1), p.72-79

2016

Link zum Volltext

Verfügbarkeit prüfen

The effect of [-2]proPSA and prostate health index (phi) on the accuracy of the prediction of initial and repeat prostate biopsies compared to tPSA and percent fPSA in young men (age 65 or younger)

Journal of clinical oncology, 2014-02, Vol.32 (4_suppl), p.171-171

2014

Link zum Volltext

Verfügbarkeit prüfen

Impact of lymphovascular invasion on oncological outcomes in patients with upper tract urothelial carcinoma after radical nephroureterectomy

BJU international, 2013-06, Vol.111 (8), p.1199-1207

2013

Link zum Volltext

Verfügbarkeit prüfen

Use of [-2]proPSA and prostate health index (phi) to improve the diagnostic accuracy of prostate cancer compared to t-PSA and %f-PSA in young men (≤ 65 years old)

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.5074-5074

2013

Link zum Volltext

Verfügbarkeit prüfen

Post-chemotherapy retroperitoneal teratoma in nonseminomatous germ cell tumors: Do predictive factors exist? Results from a national multicenter study

Journal of surgical oncology, 2016-12, Vol.114 (8), p.992-996

2016

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of urinary prostate cancer antigen‐3 (PCA3) and TMPRSS2‐ERG score changes when starting androgen‐deprivation therapy with triptorelin 6‐month formulation in patients with locally advanced and metastatic prostate cancer

BJU international, 2014-10, Vol.114 (4), p.608-616

2014

Link zum Volltext

Verfügbarkeit prüfen

Surgical Treatment of an Aneurysm of a Distal Branch of the Renal Artery

Annals of vascular surgery, 2014, Vol.28 (1), p.260.e9-260.e12

2014

Link zum Volltext

Verfügbarkeit prüfen

2054 REDUCING UNNECESSARY BIOPSIES FOR SUSPICION OF PROSTATE CANCER: EXTENSION AND VALIDATION OF AN ERSPC BASED RISK CALCULATOR WITH PHI AND COMPARISON WITH THE PCPT RISK CALCULATOR INCLUDING %FREE AND -2PROPSA

The Journal of urology, 2013-04, Vol.189 (4), p.e843-e843

2013

Link zum Volltext

Verfügbarkeit prüfen

Tissue expression of IL16 in prostate cancer and its association with recurrence after radical prostatectomy

The Prostate, 2010-11, Vol.70 (15), p.1622-1627

2010

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Two Prostate Cancer Risk Calculators that Include the Prostate Health Index

European urology focus, 2015-09, Vol.1 (2), p.185-190

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 71

Suche als RSS-Feed

Aktive Filter

KollektionOxford Journals 2020 Medicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(64)
Mit Volltextzugriff
(55)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(34)
Male
(30)
Science & Technology
(27)
Life Sciences & Biomedicine
(26)
Sciences Biologiques Et Medicales
(21)
Sciences Medicales
(21)
Middle Aged
(20)
Urology & Nephrology
(18)
Aged
(16)
Biological And Medical Sciences
(14)
Female
(14)
Medical Sciences
(14)
Urology
(14)
Adult
(12)
Retrospective Studies
(12)
Nephrologie. Maladies Des Voies Urinaires
(11)
Nephrology. Urinary Tract Diseases
(10)
Gynecologie. Andrologie. Obstetrique
(9)
Pathologie De L'appareil Génital Mâle
(9)
Tumeurs
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinomas: predictors and impact on subsequent oncological outcomes from a national multicenter study

The impact of lymph node status and features on oncological outcomes in urothelial carcinoma of the upper urinary tract (UTUC) treated by nephroureterectomy

Influence of previous or synchronous bladder cancer on oncologic outcomes after radical nephroureterectomy for upper urinary tract urothelial carcinoma

The percentage of prostate‐specific antigen (PSA) isoform [–2]proPSA and the Prostate Health Index improve the diagnostic accuracy for clinically relevant prostate cancer at initial and repeat biopsy compared with total PSA and percentage free PSA in men aged ≤65 years

A Multicentre Evaluation of the Role of the Prostate Health Index (PHI) in Regions with Differing Prevalence of Prostate Cancer: Adjustment of PHI Reference Ranges is Needed for European and Asian Settings

Congenital Pelvic Arteriovenous Malformation in Male Patients: A Rare Cause of Urological Symptoms and Role of Embolization

Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study

Ureteral and Multifocal Tumours Have Worse Prognosis than Renal Pelvic Tumours in Urothelial Carcinoma of the Upper Urinary Tract Treated by Nephroureterectomy

Outcomes After Adjuvant Chemotherapy in the Treatment of High-Risk Urothelial Carcinoma of the Upper Urinary Tract (UUT-UC): Results From a Large Multicenter Collaborative Study

Cancer du testicule

Cancer du testicule

2133 [-2]PROPSA AND PROSTATE HEALTH INDEX (PHI) IMPROVE DETECTION OF PROSTATE CANCER AT INITIAL AND REPEATED BIOPSIES IN YOUNG MEN (<60 YEAR OLD) PREFERENTIALLY DETECTING CLINICALLY SIGNIFICANT CANCER

A proportion of hereditary upper urinary tract urothelial carcinomas are misclassified as sporadic according to a multi‐institutional database analysis: proposal of patient‐specific risk identification tool

Simulation Training in Endo-urology: a New Opportunity for Training in Senegal

The percentage of prostate‐specific antigen ( PSA ) isoform [–2]pro PSA and the Prostate Health Index improve the diagnostic accuracy for clinically relevant prostate cancer at initial and repeat biopsy compared with total PSA and percentage free PSA in men aged ≤65 years

The effect of [-2]proPSA and prostate health index (phi) on the accuracy of the prediction of initial and repeat prostate biopsies compared to tPSA and percent fPSA in young men (age 65 or younger)

Impact of lymphovascular invasion on oncological outcomes in patients with upper tract urothelial carcinoma after radical nephroureterectomy

Use of [-2]proPSA and prostate health index (phi) to improve the diagnostic accuracy of prostate cancer compared to t-PSA and %f-PSA in young men (≤ 65 years old)

Post-chemotherapy retroperitoneal teratoma in nonseminomatous germ cell tumors: Do predictive factors exist? Results from a national multicenter study

Evaluation of urinary prostate cancer antigen‐3 (PCA3) and TMPRSS2‐ERG score changes when starting androgen‐deprivation therapy with triptorelin 6‐month formulation in patients with locally advanced and metastatic prostate cancer

The oncologic impact of a delay between diagnosis and radical nephroureterectomy due to diagnostic ureteroscopy in upper urinary tract urothelial carcinomas: results from a large collaborative database

Surgical Treatment of an Aneurysm of a Distal Branch of the Renal Artery

2054 REDUCING UNNECESSARY BIOPSIES FOR SUSPICION OF PROSTATE CANCER: EXTENSION AND VALIDATION OF AN ERSPC BASED RISK CALCULATOR WITH PHI AND COMPARISON WITH THE PCPT RISK CALCULATOR INCLUDING %FREE AND -2PROPSA

Tissue expression of IL16 in prostate cancer and its association with recurrence after radical prostatectomy

Comparison of Two Prostate Cancer Risk Calculators that Include the Prostate Health Index

Aktive Filter

Suchergebnisse filtern